Famotidine · FAMOTIDINE 10 mg/mL · Injection · Intravenous · Medical Purchasing Solutions, LLC
NDC 71872-7220-01 · 1 VIAL in 1 BAG / 2 mL in 1 VIAL · ANDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is 4× that.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Medical Purchasing Solutions, LLC | FAMOTIDINE 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Mylan Institutional LLC | FAMOTIDINE 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Hikma Pharmaceuticals USA Inc. | FAMOTIDINE 10 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Famotidine — NDC 71872-7220-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872722001.
Free to cite with attribution — see how the data is put together.